Predictors of Community Functioning in Schizophrenia and Substance Use Disorder Patients

被引:7
|
作者
Zhornitsky, Simon [1 ]
Aubin, Ginette [2 ]
Desfosses, Joelle [1 ]
Rizkallah, Elie [3 ]
Pampoulova, Tania [1 ,3 ]
Lipp, Olivier [1 ]
Chiasson, Jean-Pierre [3 ]
Stip, Emmanuel [1 ]
Potvin, Stephane [1 ,4 ]
机构
[1] Univ Montreal, Dept Psychiat, Fernand Seguin Res Ctr, Fac Med, Montreal, PQ H3C 3J7, Canada
[2] Ctr Hosp Univ Montreal, Occupat Therapy Serv, Montreal, PQ, Canada
[3] Clin Nouveau Depart, Montreal, PQ, Canada
[4] Ctr Rech Fernand Seguin, Montreal, PQ H1N 3V2, Canada
基金
加拿大健康研究院;
关键词
Community functioning; Schizophrenia; Substance use disorder; Memory; Depression; EXTRAPYRAMIDAL SYMPTOMS; COGNITIVE PREDICTORS; DEPRESSIVE SYMPTOMS; DUAL-DIAGNOSIS; RATING-SCALE; DRUG-ABUSE; DEFICITS; MEMORY; METAANALYSIS; COMORBIDITY;
D O I
10.1007/s10597-012-9525-y
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Community functioning is a broad term that encompasses various 'real world' measures of disability among schizophrenia patients. It includes outcomes such as independent living, social competence and behavioural problems-all of which are priorities for treatment among schizophrenia patients, mental health care providers, and family members. An important goal for rehabilitation programs is to identify predictors of community functioning which, in turn, could be used as targets for intervention. The present case-control study examined socio-demographic and substance use disorder (SUD) variables as well as psychiatric, extrapyramidal, and cognitive symptoms as predictors of community functioning in schizophrenia patients with (DD patients; n = 31) and without comorbid SUDs (SCZ patients; n = 31), and non-psychosis substance abusers (SUD patients; n = 39). Psychiatric and extrapyramidal symptoms were evaluated with the Positive and Negative Syndrome Scale, the Calgary Depression Scale for Schizophrenia and the Extrapyramidal Symptoms Rating Scale. Cognition was evaluated using the Cambridge Neuropsychological Test Automated Battery (speed of processing, explicit and working memory). In SCZ patients, community functioning was predicted by explicit memory performance. In DD patients, community functioning was predicted by substance abuse, depression and speed of processing. In SUD patients, community functioning was predicted by substance abuse, positive symptoms and education. Our results suggest that cognition should be among the top treatment priorities in SCZ patients, whereas the key treatment targets in DD patients should be substance abuse and depression. Future studies will need to replicate the current findings, using prospective research designs.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 50 条
  • [1] Predictors of Community Functioning in Schizophrenia and Substance Use Disorder Patients
    Simon Zhornitsky
    Ginette Aubin
    Joelle Desfossés
    Élie Rizkallah
    Tania Pampoulova
    Olivier Lipp
    Jean-Pierre Chiasson
    Emmanuel Stip
    Stéphane Potvin
    Community Mental Health Journal, 2013, 49 : 317 - 322
  • [2] Circadian functioning and quality of life in substance use disorder patients with and without comorbid schizophrenia
    Hashemzadeh, Iman
    Navarro, Jose Francisco
    Adan, Ana
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2023, 120
  • [3] Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia
    Jaworski, Fabienne
    Dubertret, Caroline
    Ades, Jean
    Gorwood, Philip
    PSYCHIATRY RESEARCH, 2011, 185 (1-2) : 129 - 134
  • [4] Effect of schizophrenia and substance use disorder on depressive symptoms and stressful life events
    Karabanowicz, Ewa
    Tyburski, Ernest
    Lutkiewicz, Karolina
    Radziwillowicz, Wioletta
    ARCHIVES OF PSYCHIATRY AND PSYCHOTHERAPY, 2025, 27 (01): : 97 - 105
  • [5] Treatment Outcomes of an Integrated Residential Programme for Patients with Schizophrenia and Substance Use Disorder
    Morrens, Manuel
    Dewilde, Bieke
    Sabbe, Bernard
    Dom, Geert
    De Cuyper, Raoul
    Moggi, Franz
    EUROPEAN ADDICTION RESEARCH, 2011, 17 (03) : 154 - 163
  • [6] Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population
    Jimenez-Castro, Lorena
    Raventos-Vorst, Henriette
    Escamilla, Michael
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2011, 39 (02): : 123 - 130
  • [7] Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review
    Arranz, Belen
    Garriga, Marina
    Garcia-Rizo, Clemente
    San, Luis
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (02) : 227 - 242
  • [8] Comparison of Patients with Schizophrenia, Bipolar Disorder, and Substance Use Disorder in Terms of Family Burden
    Kahya, Yalcin
    Erdogan, Ali
    Onder, Arif
    Kulaksizoglu, Burak
    Kuloglu, Mehmet Murat
    ADDICTA-THE TURKISH JOURNAL ON ADDICTIONS, 2022, 9 (01): : 16 - 22
  • [9] Neurophysiological and Psychological Predictors of Social Functioning in Patients with Schizophrenia and Bipolar Disorder
    Kim, Yourim
    Kwon, Aeran
    Min, Dongil
    Kim, Sungkean
    Jin, Min Jin
    Lee, Seung-Hwan
    PSYCHIATRY INVESTIGATION, 2019, 16 (10) : 718 - +
  • [10] Prevalence of Substance Use in Patients Diagnosed with Schizophrenia
    Tekin Uludag, Yasemin
    Gulec, Gulcan
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2016, 53 (01): : 4 - 11